GSK1349572 + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Infection, Human Immunodeficiency Virus
Conditions
Infection, Human Immunodeficiency Virus
Trial Timeline
Jun 1, 2008 → Aug 1, 2008
NCT ID
NCT00708110About GSK1349572 + Placebo
GSK1349572 + Placebo is a phase 2 stage product being developed by Shionogi for Infection, Human Immunodeficiency Virus. The current trial status is completed. This product is registered under clinical trial identifier NCT00708110. Target conditions include Infection, Human Immunodeficiency Virus.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00708110 | Phase 2 | Completed |
Competing Products
20 competing products in Infection, Human Immunodeficiency Virus